Ipamorelin is a synthetic protein fragment that stimulates the body's natural growth hormone release by mimicking ghrelin. It is being researched for its potential to improve body composition and aid in tissue repair.
Ipamorelin is a synthetic peptide belonging to the class of growth hormone-releasing peptides. Composed of five amino acids, it acts to stimulate the pituitary gland, leading to an increased release of growth hormone (GH). Unlike some other GH-releasing peptides, ipamorelin is noted for its highly selective action, primarily stimulating GH release without significantly activating the body's stress response or impacting other hormone levels. This specificity makes it a subject of considerable interest in various research applications. Research into ipamorelin suggests several potential benefits. Studies in animal models have indicated its ability to promote bone growth, with observations of increased bone mineral content and even longer limb bones. This has implications for conditions involving bone density loss, stunted growth, and recovery from bone injuries. While direct human evidence is still emerging, these findings provide a foundation for understanding its potential in skeletal health. Muscle growth is another prominent area of investigation for ipamorelin. Although definitive scientific studies directly linking ipamorelin to significant increases in skeletal muscle mass are limited, preclinical research has shown promise in counteracting muscle wasting induced by certain corticosteroids. This suggests a role in maintaining muscle integrity and potentially supporting muscle development. Its classification as a prohibited substance in competitive sports further hints at its perceived efficacy in enhancing athletic performance and body composition. Beyond bone and muscle, ipamorelin may also contribute to improved vascularity and collagen synthesis. As a ghrelin mimetic, it could indirectly support angiogenesis, the formation of new blood vessels, a process crucial for tissue regeneration and cardiovascular health. Furthermore, by mimicking ghrelin, it is hypothesized to aid in the repair and regeneration of cartilage, joints, and skin by upregulating cartilage-specific genes and supporting mesenchymal stem cell differentiation towards cartilage repair. These broader regenerative properties highlight its potential for anti-aging and tissue recovery applications.
Ipamorelin functions as a selective growth hormone secretagogue and an agonist of the ghrelin receptor. It initiates growth hormone production by mimicking the action of ghrelin, stimulating somatocrinin release, and inhibiting somatostatin. This leads to a targeted increase in growth hormone without significantly affecting other hormones.
Typical dosing ranges from 200 to 300 micrograms per day, administered subcutaneously. It is generally recommended to start with the lowest effective dose and adjust as needed based on research objectives. Administered daily, often in cycles of 8-12 weeks followed by a 4-week break. Doses of 200 micrograms or more per day can be divided into 2-3 injections.
Ipamorelin has not received approval for human use from the FDA or international regulatory bodies. While existing research indicates a favorable safety profile with minimal reported side effects, the limited number of comprehensive human clinical trials means that the full spectrum of potential side effects and long-term safety implications remains largely unknown. Exercise caution, and only qualified researchers should handle and administer this peptide. It is prohibited by the World Anti-Doping Agency.
Sermorelin is a synthetic peptide that functions as a growth hormone-releasing hormone analog, stimulating the body's natural production and release of growth hormone. It was initially developed for treating growth hormone deficiency in both children and adults.
100-200 mcgGrowth Hormone Releasing Peptide-2
A growth hormone releasing peptide that stimulates natural GH secretion. Works synergistically with GHRH analogues for enhanced growth hormone release.
100-300 mcgIbutamoren Mesylate
MK-677 is an orally active, non-peptide compound that functions as a ghrelin receptor agonist and growth hormone secretagogue, leading to increased secretion of growth hormone and insulin-like growth factor 1, potentially enhancing body composition, sleep quality, and bone density.
12.5-25 mgGrowth Hormone Releasing Peptide-6
A potent growth hormone secretagogue that stimulates the pituitary gland. Increases appetite and GH levels with potential effects on body composition.
100-300 mcg